Viewing Study NCT06271005


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-02-24 @ 12:48 PM
Study NCT ID: NCT06271005
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-21
First Post: 2024-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves
Sponsor: Genetic Disease Investigators
Organization:

Study Overview

Official Title: Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a study on neurological dry eye disease, focusing on a patented over-the-counter supplement supporting tear production neurologically, including the lacrimal and vagus nerves.
Detailed Description: Chronic inflammation is implicated in the majority of chronic dry eyes. The parasympathetic nervous system is responsible for both basal tear secretion (the aqueous layer) by the lacrimal functional unit, and is responsible for controlling many aspects of chronic inflammation via the vagus nerve.

This study will document its effects on dry eyes, in addition to other symptoms/signs of low parasympathetic nervous system functioning using an over-the-counter supplement.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: